BAN

(redirected from mesalamine)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.

BAN

Ban

A subdivision of the Moldovan leu or Romanian leu. One ban is equal in value to 1/100 of one leu. Its plural is bani.

BAN

References in periodicals archive ?
company, has launched in the US and begun commercial shipment of a generic version of Canasa, (mesalamine) Suppository, in 1,000 mg strength, the company said.
Pharmaceutical company Mylan NV (NASDAQ:MYL) reported on Monday the availability of Mesalamine Delayed-Release Tablets USP in 1.2 g in the US gastroenterology market.
The patient was resuscitated and rehabilitated and given glucocorticoid, mesalamine, and azathioprine.
(3) Mesalamine positive control group: 3% DSS + 7.4 mg/kg mesalamine daily by gavage for 7 days
Current medications at time of visit to the ED included mesalamine and Levothyroxine.
The clinical effectiveness of mesalamine suspension enema for the treatment of UC has been established based mainly on direct contact with the damaged colonic mucosa.
* Aminosalicylates, such as mesalamine (Lialda), mesalamine extended-release (Apriso), olsalazine (Dipentum), and balsalazide (Colazal)
Mesalamine (USAN), also known as mesalazine (INN, BAN) or 5-aminosalicylic acid (5-ASA), is most commonly used as a first-line therapy for mild to moderate UC [10].
All patients were using mesalamine (50 mg/kg/day) plus azathioprine (2-2.5 mg/kg/day) but two patients with Crohn's disease, one female with perianally penetrating disease and one male with drug resistance, were on Infliximab (IFX) therapy.
Early results supporting mesalamine as chemoprophylaxis did not hold up in later trials.
Fifty patients with mild-to-moderate ulcerative colitis that had failed to respond sufficiently to mesalamine were randomly assigned to receive, in double-blind fashion, 3 g per day of curcumin (in 2 divided doses per day before meals) or placebo for 1 month, while continuing mesalamine.
Treatment with common IBD therapies such as azathioprine, mesalamine, and corticosteroids did not affect rates of cervical neoplasia, but women with Crohn's disease who had used tumor necrosis factor-alpha antagonists had an 85% increase in highgrade intraepithelial cervical lesions.